LXRX smart money
Lexicon Pharmaceuticals, INC. (LXRX): 4 insider buys, 3 top funds holding it, 1 ETF change in the public filings.
Insider buys, 12 months$2.7M
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-02-25 | Debbane Raymond | Director | $147k | $1.47 |
| 2026-02-23 | Debbane Raymond | Director | $220k | $1.48 |
| 2026-02-18 | Debbane Raymond | Director | $353k | $1.31 |
| 2026-02-04 | Artal Group S.A. | Director,TenPercentOwner | $2.0M | $1.3 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 50 | Siren, L.L.C. | 1.97% | $83M | |
| 75 | Sessa Capital Im, L.P. | TRIM -24% | 0.44% | $27M |
| 86 | Adar1 Capital Management, LLC | 0.07% | $1M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| State Street(R) Spdr(R) S&p(R) Pharmaceuticals ETF | BUY | +$3M | 2026-06-30 |